How prevalent is hyperkalemia and renal dysfunction during treatment with spironolactone in patients with congestive heart failure?
Morten Svensson, Finn Gustafsson, Søren Galatius, Per R Hildebrandt, Dan Atar
105Citations
(Scopus)
Fingerprint
Dive into the research topics of 'How prevalent is hyperkalemia and renal dysfunction during treatment with spironolactone in patients with congestive heart failure?'. Together they form a unique fingerprint.
Medicine and Dentistry
Nursing and Health Professions
Pharmacology, Toxicology and Pharmaceutical Science